24
Views
3
CrossRef citations to date
0
Altmetric
Review

Advances in the staging of renal cell carcinoma

&
Pages 673-680 | Published online: 10 Jan 2014

References

  • Northway RO, Ritenour CWM, Marshall FE Renal cell carcinoma: an overview. AUA Update Series 20 (25), 194–200 (2002) .
  • Jemal A, Thomas A, Murray T, Thun M. Cancer Statistics, 2002. CA Cancer 1 Clinicians 52,23–47 (2002).
  • Flocks RH, Kadesky MC. Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more. J. Urol 79,196–201 (1958).
  • •Original renal cell carcinoma staging system proposed by Flocks and Kadesky in 1958.
  • Robson CJ. Radical nephrectomy for renal cell carcinoma. J. Urol. 89,37–42 (1963).
  • Robson CJ, Churchill BM, Anderson W The results of radical nephrectomy for renal cell carcinoma.j Urol. 101,297–301 (1969).
  • ••Modifications to the Flocks staging systemsuggested by Robson that maintains its popularity among physicians.
  • Holland JM. Cancer of the kidney — natural history and staging. Cancer 32, 1030–1042 (1973).
  • Skinner DG, Colvin RB, Vermillion CD et al Diagnosis and management of renal cell carcinoma. Cancer 28,1165–1177 (1971).
  • •Demonstrates that renal vein involvement by itself does not significantly alter survival when compared with Ti tumors.
  • McNichols DVV, Segura JVV, de Weerd JH. Renal cell carcinoma: long-term survival and late recurrence. J. Uml. 126,17-23 (1981).
  • Vircli JS, Kelly DG. Prognostic value of renal venous involvement in renal carcinoma. Br. J. Uml. 69,481–485 (1992).
  • Guinan P, Saffrin R, Stuhldreher D, Frank W Rubenstein M. Renal cell carcinoma: comparison of the TNM and Robson stage groupings. J. Surgical Oncology 59,186–189 (1995).
  • •Good comparison between the two widely-used staging systems.
  • Guinan P, Vogelzang NJ, Fremgen AM et al Renal cell carcinoma: tumor size, stage andsurvival.j Um/. 153,901–903 (1995).
  • Bassil B, Dosoretz DE, Prout GR. Validation of the tumor, nodes and metastasis classification of renal cell carcinoma. J. Uml. 134,450–454 (1985).
  • Sobin LH, Hermanek P, Huller RVP TNM classification of malignant tumors: a comparison between the new (1987) and the old editions. Cancer61, 2310–2314 (1988).
  • •Compares the two TNM staging systems.
  • Hermanek P, Schrott KM. Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. J. Uml. 144,238–242 (1990).
  • Targonski PV, Frank W Stuhldreher D, Guinan P Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastasis stage 1 and stage 2 patients. J. Urol. 152,1389-1392 (1994).
  • Schroder FH, Cooper EH, Debruyne FMJ et al. TNM classification of genitourinary tumours 1987 — position of the EORTC genitourinary group. Br. J. Urol 62,502–510 (1988).
  • •Arguments against the revisions in the 1987 TNM staging system.
  • Gettman MT, Blute ML, Spotts B, Bryant SC, Zincke H. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system. Cancer91,354–361 (2001).
  • ••Study showing the efficacy and validity ofthe new 1997 TNM staging system.
  • Moch H, Gasser T, Amin M et a/. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a swiss experience with 588 tumors. Cancer 89, 604–614 (2000).
  • Javidan J, Stricker HJ, Tamboli P et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J. Uml. 162,1277-1281 (1999).
  • ••Another study demonstrating thesignificance of the 1997 TNM staging system.
  • Tsui KH, Shvarts O, Smith RB et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 163,1090-1095 (2000).
  • Zisman A, Pantuck AJ, Dorey F et al. Improved prognostication of renal cell carcinoma using an integrated staging system. 1 Clin. arca 19,1649–1657 (2001).
  • •Suggests the inclusion of other parameters such as histological grade and performance status in staging RCC.
  • Harmer M. 77VMCIassification of Malignant Tumour International Union Against Cancer, Geneva, Switzerland (1978).
  • Hermanek P, Sobin LH. TAM Classification of Malignant THROWS, Springer-Verlag, Berlin, Germany (1987).
  • Sobin LH, Wittekind C, International Union Against Cancer ((1CC): TAM Classification of Malignant Tumours, Wiley-Liss Publications, NY, USA, (1997).
  • Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNNI staging. J. Urol. 162,1930-1933 (1999).
  • Polascik TJ, Marshall FE Partial nephrectomy for renal tumors. AUA Update 5eries20(21), 162–168 (2001).
  • Novick AC. Nephron-sparing surgery for renal cell carcinoma. Ann. Rev Med. 53, 393–407 (2002).
  • ••Latest overview on the role of nephron-sparing stirgery.
  • Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral rebal cell carcinoma and a normal contralateral kidney. Mayo Clin. Proc. 75 (12), 1233–1235 (2000).
  • Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 Tumor-Node-Metastasis staging system. J. Clin. arca 9, 2868–2875 (1999).
  • Ghavamian R, Zincke H. Nephron-sparing Surgery. CUIT: Um]. Reports 2,34–39 (2001).
  • •Reviews the current opinion regarding nephron-sparing stu-gery.
  • Ghavamian R, Cheville JC, Lohse CM et al. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J. Urol. 168,454–459 (2002).
  • Lerner SE, Hawkins CA, Blute ML et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J. Urol. 155, 1868–1873 (1996).
  • Lee CT, Katz J, Shi W et al Surgical management of renal tumors 4 cm or less in a contemporary cohort. J. Urol 163,730 (2000).
  • Russo P, Goetzl M, Simmons R et al. Partial nephrectomy: the rationale for expanding the indications. Ann. Surg. Oncol. 9(7), 680–687 (2002).
  • McClennan BL. Oncologic imaging: staging and follow-up of renal and adrenal carcinoma. Cancer 67,1199–1208 (1991).
  • Bechtold RE, Zagoria RJ. Imaging approach to staging of renal cell carcinoma. Urologic Clin. N. Am. 24,507–522 (1997).
  • Cohan RH. Detection and characterization of renal masses and staging of renal cancers: new considerations in the era of helical computed tomography. Sem Urol. Oncol. 20 (3), 166–173 (2002) .
  • •Reviews the latest imaging advances in assessing RCC.
  • Dinney CPN, Awad SA, Gajewski JB et al. Analysis of imaging modalities, staging systems and prognostic indicators for renal cell carcinoma. Urol. 39,122–129 (1992).
  • Zagoria RJ, Bechtold RE, Dyer RB. Staging of renal adenocarcinoma: role of various imaging procedures. Arm j Roentgenol. 164, 363–370 (1995).
  • Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J. Urol 166,6–18 (2001).
  • Tsui KH, Shvarts O, Barbaric Z et al. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. j Urol. 163(2), 437–441 (2000).
  • Moudouni SM, En-Nia I, Patard JJ et al. Real indications for adrenalectomy in renal cell carcinoma. Scand. I Urol. Nephrol. 36(4), 273–277 (2002).
  • Wunderlich H, Schlichter A, Reichelt O et al. Real indications for adrenalectomy in renal cell carcinoma. European Urol. 35(4), 272–276 (1999).
  • Ditonno P, Traficante A, Battaglia M, Grossi FS, Selvaggi FR Role of lymphadenectomy in renal cell carcinoma. Frog. Gun. Biol. Res. 378,169–174 (1992).
  • Blom JHIVI, van Poppel H, Marechal JM et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized Phase III protocol 30881. European Urol. 36(6), 570–575 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.